Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Aug 30:12:724725.
doi: 10.3389/fphar.2021.724725. eCollection 2021.

Current Molecular Therapeutic Agents and Drug Candidates for Mycobacterium abscessus

Affiliations
Review

Current Molecular Therapeutic Agents and Drug Candidates for Mycobacterium abscessus

Nguyen Thanh Quang et al. Front Pharmacol. .

Abstract

Mycobacterium abscessus has been recognised as a dreadful respiratory pathogen among the non-tuberculous mycobacteria (NTM) because of misdiagnosis, prolonged therapy with poor treatment outcomes and a high cost. This pathogen also shows extremely high antimicrobial resistance against current antibiotics, including the anti-tuberculosis agents. Therefore, current chemotherapies require a long curative period and the clinical outcomes are not satisfactory. Thus, there is an urgent need for discovering and developing novel, more effective anti-M. abscessus drugs. In this review, we sum the effectiveness of the current anti-M. abscessus drugs and drug candidates. Furthermore, we describe the shortcomings and difficulties associated with M. abscessus drug discovery and development.

Keywords: Mycobacterium abscessus; anti-M. abscessus; antibiotics; drug discovery; drug resistance.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
Mechanisms of action (MOA) of anti-Mab drugs and drug candidates.

References

    1. Abate G., Hamzabegovic F., Eickhoff C. S., Hoft D. F. (2019). BCG Vaccination Induces M. Avium and M. Abscessus Cross-Protective Immunity. Front. Immunol. 10, 234. 10.3389/fimmu.2019.00234 - DOI - PMC - PubMed
    1. Abdalla M. Y., Switzer B. L., Goss C. H., Aitken M. L., Singh P. K., Britigan B. E. (2015). Gallium Compounds Exhibit Potential as New Therapeutic Agents against Mycobacterium Abscessus. Antimicrob. Agents Chemother. 59, 4826–4834. 10.1128/AAC.00331-15 - DOI - PMC - PubMed
    1. Abdulrahman B. A., Abdelaziz D., Thapa S., Lu L., Jain S., Gilch S., et al. (2017). The Celecoxib Derivatives AR-12 and AR-14 Induce Autophagy and clear Prion-Infected Cells from Prions. Sci. Rep. 7, 17565. 10.1038/s41598-017-17770-8 - DOI - PMC - PubMed
    1. Adjemian J., Olivier K. N., Prevots D. R. (2018). Epidemiology of Pulmonary Nontuberculous Mycobacterial Sputum Positivity in Patients with Cystic Fibrosis in the United States, 2010-2014. Ann. ATS 15, 817–826. 10.1513/AnnalsATS.201709-727OC - DOI - PMC - PubMed
    1. Akbarzadeh A., Rezaei-Sadabady R., Davaran S., Joo S. W., Zarghami N., Hanifehpour Y., et al. (2013). Liposome: Classification, Preparation, and Applications. Nanoscale Res. Lett. 8, 102. 10.1186/1556-276X-8-102 - DOI - PMC - PubMed

LinkOut - more resources